Mostrar el registro sencillo del ítem

dc.contributor.author
Coban, Ahmet Yilmaz  
dc.contributor.author
Alakbarova, Gumral  
dc.contributor.author
Satti, Luqman  
dc.contributor.author
Tayyab, Nadia  
dc.contributor.author
Zaman, Gohar  
dc.contributor.author
Morcillo, Nora Susana  
dc.contributor.author
Imperiale, Belén Rocío  
dc.contributor.author
Wainmayer, Ingrid  
dc.contributor.author
Símboli, Norberto Fabián  
dc.date.available
2020-01-28T17:43:32Z  
dc.date.issued
2018-10  
dc.identifier.citation
Coban, Ahmet Yilmaz; Alakbarova, Gumral; Satti, Luqman; Tayyab, Nadia; Zaman, Gohar; et al.; Crystal violet decolorization assay for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates: A multicenter study; Medknow Publications; International Journal of Mycobacteriology; 7; 4; 10-2018; 310-314  
dc.identifier.issn
2212-5531  
dc.identifier.uri
http://hdl.handle.net/11336/95989  
dc.description.abstract
Background: Effective control of tuberculosis is achieved by early diagnosis and drug susceptibility testing for initiation of appropriate treatment. The performance of crystal violet decolorization assay (CVDA) for susceptibility testing of Mycobacterium tuberculosis to isoniazid (INH) and rifampicin (RIF) was compared in a multicenter study. Methods: Seventy-two M. tuberculosis isolates were tested in two phases by CVDA. Results: In Phase I, the specificity, sensitivity, positive predictive value (PPV), negative predictive value (NPV), and agreement for INH were 100%, respectively. Specificity, sensitivity, PPV, NPV, and agreement for RIF were 98.2%, 100%, 94.1%, 100%, and 98.6%, respectively. In Phase II, specificity, sensitivity, PPV, NPV, and agreement were 98%, 100%, 95.4%, 100%, and 98.6% for INH, respectively. Specificity, sensitivity, PPV, NPV, and agreement for RIF were 96.3%, 88.2%, 88.2%, 96.3%, and 94.4%, respectively. Results in the study were obtained on average 10.9 ± 3.1 days in Phase I and 9.8 ± 2.2 days in Phase II. Conclusion: CVDA can be performed for drug susceptibility testing in developed and developing countries. In addition, further studies with larger sample size are needed for evaluation of this method.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Medknow Publications  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
CRYSTAL VIOLET DECOLORIZATION ASSAY  
dc.subject
ISONIAZID  
dc.subject
MULTIDRUG RESISTANT  
dc.subject
MYCOBACTERIUM TUBERCULOSIS  
dc.subject
RIFAMPICIN  
dc.subject.classification
Biología Celular, Microbiología  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Crystal violet decolorization assay for rapid detection of multidrug-resistant Mycobacterium tuberculosis isolates: A multicenter study  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2019-10-18T18:03:23Z  
dc.identifier.eissn
2212-554X  
dc.journal.volume
7  
dc.journal.number
4  
dc.journal.pagination
310-314  
dc.journal.pais
India  
dc.description.fil
Fil: Coban, Ahmet Yilmaz. Akdeniz Üniversitesi; Turquía  
dc.description.fil
Fil: Alakbarova, Gumral. Medical Microbiology Laboratory. Thalassemia Center; Azerbaiyán  
dc.description.fil
Fil: Satti, Luqman. Armed Forces Institute of Pathology; Pakistán  
dc.description.fil
Fil: Tayyab, Nadia. Armed Forces Institute of Pathology; Pakistán  
dc.description.fil
Fil: Zaman, Gohar. Armed Forces Institute of Pathology; Pakistán  
dc.description.fil
Fil: Morcillo, Nora Susana. Provincia de Buenos Aires. Ministerio de Salud. Hospital "Dr. Antonio A. Cetrángolo"; Argentina  
dc.description.fil
Fil: Imperiale, Belén Rocío. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Wainmayer, Ingrid. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina  
dc.description.fil
Fil: Símboli, Norberto Fabián. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina  
dc.journal.title
International Journal of Mycobacteriology  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.4103/ijmy.ijmy_141_18  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=4;spage=310;epage=314;aulast=Coban